Status:
COMPLETED
tDCS to Lower Neuropathic Pain and Fatigue in People With Multiple Sclerosis
Lead Sponsor:
University of Iowa
Collaborating Sponsors:
jkamholz
Workman, Craig D., PhD
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate the effects of transcranial direct current stimulation (tDCS) on neuropathic pain and fatigue in people with MS. The investigators will conduct tDCS or sham...
Detailed Description
Prospective participants, men and women with MS, will be recruited. To accomplish this study, 20 participants will need to complete 2 randomly-ordered blocks of protocols (tDCS or sham), separated by ...
Eligibility Criteria
Inclusion
- Medically diagnosed with Multiple Sclerosis
- 18-70 yrs. of age, moderate disability (Patient Determined Disease Steps (PDDS) core 2-6)
- Self-reported differences in function between legs
- Able to walk for 6 min
- Presenting with chronic, drug-resistant, neuropathic pain.
Exclusion
- Relapse within last 60 days
- High risk for cardiovascular disease (ACSM risk classification)
- Changes in disease modifying medications within last 45 days
- Concurrent neurological/neuromuscular disease
- Hospitalization within last 90 days
- Diagnosed depression
- Inability to understand/sign informed consent.
Key Trial Info
Start Date :
April 15 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2020
Estimated Enrollment :
6 Patients enrolled
Trial Details
Trial ID
NCT03870048
Start Date
April 15 2019
End Date
March 30 2020
Last Update
August 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Iowa
Iowa City, Iowa, United States, 52242